Investor Relations

Orpyx® Medical Technologies creates long-term shareholder value by innovating accessible technology that addresses the growing demand for digital self-monitoring devices. Our initial market entry strategy will focus on developing solutions that address an increasingly prevalent complication of diabetes mellitus, peripheral neuropathy. The viability of this market approach is strengthened by the relationships that have been established with key opinion leaders in diabetic foot care, and Orpyx® authoritative first mover advantage position.

One of the ways that we are mitigating risk and ensuring value for our shareholders, is by concurrently exploring applications in athletic markets. With minor software adjustments, we can adapt our core technology to provide enormous self-diagnostic benefits to athletes in a wide range of sports such as running, soccer and golf to name a few.

Orpyx® strategy for success is straightforward. The company was founded by a group of physicians, engineers and business people with strong track records of success and leadership in their respective specialty areas. Our common interest is a passion for developing sensor-based technologies that enable people to reach their full potential.

For more information please download our corporate summary, or contact Dr. Breanne Everett, Orpyx® CEO & President via e-mail at

Orpyx Medical Technologies - Corporate Summary
Last updated: August 21, 2013